Research-use-only 27-gene expression assay
Tumor immune microenvironment research
Research Use OnlyAvailable
Key Facts
Indication
Tumor immune microenvironment research
Phase
Research Use Only
Status
Available
About Insight Molecular Diagnostics
iMDx is dedicated to advancing precision medicine by making critical molecular diagnostic tests more accessible in transplantation and oncology. The company has pivoted under CEO Josh Riggs to decentralize its testing approach, offering both clinical assays and research-use-only kits. With a leadership team combining decades of diagnostics experience, iMDx is developing non-invasive monitoring tools for organ rejection and cancer treatment response, targeting two of the fastest-growing areas in diagnostics.
View full company profile